More Genfleet Therapeutics (Shanghai), Inc. news
Genfleet Therapeutics (Shanghai), Inc.HKEX: 2595

Next Day Disclosure Return

Nov 20, 2026 at 5:46 AM EST · Issued by Genfleet Therapeutics (Shanghai), Inc. via HKEXnews

Filed with HKEX · Stock code 2595 · Nov 20, 2026 at 5:46 AM EST · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-3214

Genfleet Therapeutics (Shanghai), Inc. on 6ix

Earlier from Genfleet Therapeutics (Shanghai)

  • VOLUNTARY ANNOUNCEMENT First Patients Dosed Respectively in China and Overseas in a Combinational Study of GFH276 (Pan RAS Inhibitor), with Three Front-line Combination Regimens Treating Pancreatic Cancer to be Evaluated in Phase II TrialNov 16
  • VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share RepurchaseNov 9
  • Share repurchaseNov 8
  • Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026Nov 4
All Genfleet Therapeutics (Shanghai) news releases↗

Follow Genfleet Therapeutics (Shanghai) into a list and get an email when it puts out news.

Follow Genfleet Therapeutics (Shanghai)
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer